James Rolke

Affiliations

  • Chief Executive Officer at Revelation Biosciences Inc. (REVB), 2023-02-28
  • Chief Scientific Officer at La Jolla Pharmaceutical Co (LJPC), 2020-06-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LJPC $6.10 800 Officer 76,330 2019-01-09 Filing
LJPC $6.09 500 Officer 75,530 2019-01-09 Filing
LJPC $6.07 300 Officer 75,030 2019-01-09 Filing
LJPC $22.00 1,000 Officer 74,328 2018-08-16 Filing